The Breast Residual Cancer Burden (RCB) measures residual disease after
neodjuvant therapy. This prognostic indicator is based on the
post-treatment surgical resection specimen node densities and counts.
The summary Index and Class are calculated as described in
<a href='http://ascopubs.org/doi/abs/10.1200/JCO.2007.10.6823' target='_blank'>
JCO 25:28 4414-4422
</a>
.
